Global mapping of BMAL1 protein-DNA interactions in human retinal Müller cells

Qianyi Luo1, Neel Sangani2, Surabhi Abhyankar1

  • 1Department of Ophthalmology, Indiana University School of Medicine, Eugene and Marilyn Glick Eye Institute, Indianapolis, IN.

Molecular Vision
|February 17, 2025
PubMed

Insights

Researchers mapped BMAL1 binding sites in human Müller cells, revealing key genes involved in circadian regulation and retinal health. This work offers potential for treating circadian-related eye diseases.

Area of Science:

  • Ophthalmology
  • Chronobiology
  • Molecular Biology

Background:

  • The circadian clock regulates physiological processes, but its role in peripheral clocks, especially in human Müller cells, is not well understood.
  • Müller cells are crucial for retinal homeostasis and may offer insights into circadian regulation within the eye.

Purpose of the Study:

  • To comprehensively map BMAL1 binding sites in human Müller cells.
  • To identify genes and biological processes regulated by BMAL1 in these cells.
  • To explore the therapeutic potential for circadian-related retinal diseases.

Main Methods:

  • Chromatin immunoprecipitation sequencing (ChIP-sequencing) was used to identify BMAL1 binding sites.
  • Bioinformatic analysis was performed to analyze peak distribution, gene enrichment, and motif discovery.
  • Quantitative PCR (qPCR) was employed to validate circadian target genes.

Main Results:

  • 275 reproducible BMAL1 binding sites were identified, predominantly in promoters, introns, and intergenic regions.
  • 89 unique genes were significantly enriched with BMAL1 promoter binding, involved in circadian regulation and photoperiodism.
  • A conserved CACGTG motif was found in 89.09% of peaks, and qPCR validated known and novel targets like G6PC3, CIART, PER1, TXNIP, SHMT2, and MALAT1.

Conclusions:

  • This study elucidates the BMAL1 regulatory landscape in human Müller cells, expanding the understanding of clock mechanisms in ocular tissues.
  • The identified BMAL1 targets are critical for Müller cell health and suggest potential therapeutic strategies for circadian-related retinal disorders.
  • These findings open avenues for chronotherapeutic interventions in ophthalmology.